Echo Therapeutics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Echo Therapeutics generated cash of -$5,079,864, which is more than the previous year. Cash used in financing activities reached the amount of $3,970,825 last year. Net change in cash is therefore -$1,222,731.

Cash Flow

Echo Therapeutics, Inc. (OTC:ECTE): Cash Flow
2012 -10.28M -1.64M 6.68M
2013 -19.40M -144.03K 23.86M
2014 -10.72M 215.44K 3.73M
2015 -5.07M -113.69K 3.97M

ECTE Cash Flow Statement (2012 – 2015)

2015 2014 2013 2012
Cash at beginning of period
1.27M8.05M3.74M8.99M
Operating activities
Net income
-22.19M-14.96M-19.06M-12.33M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
521.86K392.72K391.59K145.15K
Stock-based compensation expense
910.88K1.37M1.24M1.40M
Deferred income tax benefit 910.88K1.37M1.24M1.40M
Changes in operating assets and liabilities:
Accounts receivable, net
00037.06K
Inventories
0000
Accounts payable
656.55K765.14K-1.28M1.95M
Cash generated by operating activities
-5.07M-10.72M-19.40M-10.28M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-55.83K-36.62K-249.00K-1.48M
Acquisitions Net
0000
Cash generated by investing activities
-113.69K215.44K-144.03K-1.64M
Financing activities
Common Stock Issued
3.58M3.29M26.86M3.49M
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0-1.36K0-2.28K
Cash used in financing activities
3.97M3.73M23.86M6.68M
Net Change In Cash
-1.22M-6.77M4.30M-5.24M
Cash at end of period
56.21K1.27M8.05M3.74M
Data sourceData sourceData sourceData source